We conducted a comprehensive flow cytometry study to determine the frequency of CD4+ T cell subsets including Th1, Th2, Th17, Tfh, Treg, and CTLA-4+ Treg in the PBMCs of 59 healthy donors and 40 untreated MG patients. This evidence concerns the gene CD4 and myasthenia gravis.